To comprehensibly understand the genes and pathways associated with TMIGD2 expression in LSCs, transcriptome-wide RNA-seq was conducted on FACS-purified CD34+TMIGD2+ and CD34+TMIGD2- subfractions of six primary AML specimens. The gene discussed is CD34; the disease is acute myeloid leukemia.